HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma.

AbstractBACKGROUND:
Despite its wide use, catheter tract recurrence after percutaneous biliary drainage (PBD) is rarely reported. However, one recent large-scale study reported a catheter tract recurrence rate as high as 5.2 % in patients with perihilar or distal bile duct cancer. We report on our 20 years of experience with catheter tract seeding after PBD for hilar cholangiocarcinoma.
METHODS:
The medical records of 441 patients who underwent operation for hilar cholangiocarcinoma between 1991 and 2011 were retrospectively analyzed.
RESULTS:
Of the 441 patients with hilar cholangiocarcinoma, PBD was performed in 315 patients, and 232 others underwent resection of hilar cholangiocarcinoma with PBD. Catheter tract recurrence developed in 6 patients (2.6 %). The median drainage duration was 30 days, and 1 patient had multiple PBDs. The median time to catheter recurrence after surgery was 10.9 months. Three patients underwent curative resection of the abdominal wall followed by chemotherapy, 1 patient underwent chemotherapy only, and 2 patients received conservative treatment. Five patients in whom the catheter tract recurrence was their first recurrence died of systemic recurrence at median 3.9 months after detection of catheter tract seeding. T1 or 2 disease (66.7 vs. 31.3 %; p = 0.086) tended to have catheter tract seeding with marginal significance. The overall survival rate was lower in patients with catheter tract seeding than in those without (median 17.5 vs. 23.0 months; p = 0.089).
CONCLUSIONS:
The PBD catheter tract recurrence rate for hilar cholangiocarcinoma was 2.6 %. However, patients with catheter tract recurrence had a poor prognosis despite complete surgical metastasectomy.
AuthorsMee Joo Kang, Yun-Suk Choi, Jin-Young Jang, In Woong Han, Sun-Whe Kim
JournalWorld journal of surgery (World J Surg) Vol. 37 Issue 2 Pg. 437-42 (Feb 2013) ISSN: 1432-2323 [Electronic] United States
PMID23188530 (Publication Type: Case Reports, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Bile Duct Neoplasms (mortality, pathology, surgery, therapy)
  • Bile Ducts, Intrahepatic (pathology, surgery)
  • Catheterization (adverse effects)
  • Cholangiocarcinoma (mortality, secondary, surgery)
  • Combined Modality Therapy
  • Drainage (adverse effects, methods)
  • Female
  • Hepatectomy
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Seeding
  • Pancreaticoduodenectomy
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: